Title |
Propyl-2-(8-(3,4-Difluorobenzyl)-2′,5′-Dioxo-8-Azaspiro[Bicyclo[3.2.1] Octane-3,4′-Imidazolidine]-1′-yl) Acetate Induces Apoptosis in Human Leukemia Cells through Mitochondrial Pathway following Cell Cycle Arrest
|
---|---|
Published in |
PLOS ONE, July 2013
|
DOI | 10.1371/journal.pone.0069103 |
Pubmed ID | |
Authors |
Chandagirikoppal V. Kavitha, Mridula Nambiar, Pavan B. Narayanaswamy, Elizabeth Thomas, Ujjwal Rathore, Channapillekoppalu S. Ananda Kumar, Bibha Choudhary, Kanchugarakoppal S. Rangappa, Sathees C. Raghavan |
Abstract |
Due to the functional defects in apoptosis signaling molecules or deficient activation of apoptosis pathways, leukemia has become an aggressive disease with poor prognosis. Although the majority of leukemia patients initially respond to chemotherapy, relapse is still the leading cause of death. Hence targeting apoptosis pathway would be a promising strategy for the improved treatment of leukemia. Hydantoin derivatives possess a wide range of important biological and pharmacological properties including anticancer properties. Here we investigated the antileukemic activity and mechanism of action of one of the potent azaspiro hydantoin derivative, (ASHD). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 2 | 11% |
Unknown | 17 | 89% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 4 | 21% |
Student > Ph. D. Student | 3 | 16% |
Student > Master | 2 | 11% |
Other | 1 | 5% |
Student > Bachelor | 1 | 5% |
Other | 4 | 21% |
Unknown | 4 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 4 | 21% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 11% |
Biochemistry, Genetics and Molecular Biology | 2 | 11% |
Business, Management and Accounting | 1 | 5% |
Unspecified | 1 | 5% |
Other | 4 | 21% |
Unknown | 5 | 26% |